Angptl8 is a negative regulator in pathological cardiac hypertrophy

HIGHLIGHTS

• who: Lin Hu from the Study population and ethical statement We recruited , subjects from the Affiliated Taihe Hospital of Hubei University of Medicine into this study, including , healthy people, patients with hypertension, and , patients with hypertension and left ventricular hypertrophySubjects with hypertension were defined as having a systolic blood pressure u2265, mmHg and/or a diastolic blood pressure u2265, mmHg at the initial visitor or those using antihypertensive medication [11, ]. Left ventricular hypertrophy was diagnosed by ultrasonic echocardiography and/or electrocardiogram and/or porcine magnetic resonance imaging (MRI). The control group was composed of healthy individuals without . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.